Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Korea S.E.
14/08/2026
|
5-day change | 1st Jan Change | ||
| 201,000.00 KRW | -0.50% |
|
+0.85% | +16.60% |
| 08-04 | Celltrion Files Phase 3 Trial Amendment for CT-P44 Biosimilar for Myeloma | MT |
| 07-24 | Celltrion Submits EMA Marketing Authorization Application for Cosentyx Biosimilar CT-P55 | MT |
| Market Cap | 46,095B 32.61B 28.16B 26.47B 24.07B 45.25B 3,118B 46B 310B 121B 1,561B 122B 120B 5,189B | P/E 2026 * |
30.6x | P/E 2027 * | 26.4x |
|---|---|---|---|---|---|
| Enterprise Value | 48.07B 34.01M 29.37M 27.6M 25.1M 47.19M 3.25B 47.97M 323M 126M 1.63B 128M 125M 5.41B | EV / Sales 2026 * |
8.82x | EV / Sales 2027 * | 7.49x |
| Free-Float |
58.26% | Yield 2026 * |
0.38% | Yield 2027 * | 0.41% |
| 1 day | -0.50% | ||
| 1 week | +0.85% | ||
| Current month | +7.66% | ||
| 1 month | +14.40% | ||
| 3 months | +11.78% | ||
| 6 months | -11.32% | ||
| Current year | +16.60% |
| 1 week | 194,850 |  | 212,000 |
| 1 month | 168,200 | | 212,000 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 158,500 | | 239,047.62 |
| 3 years | 114,250.83 | | 239,047.62 |
| 5 years | 114,250.83 | | 247,058.06 |
| 10 years | 64,487.59 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 50 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 1/16/26 A | Sell | 500 | 0.0002% | |||
| 1/16/26 A | Sell | 1,000 | 0.0004% | |||
| 1/16/26 A | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.50% | +0.85% | +20.60% | +49.65% | 32.61B | |
| -1.78% | -1.68% | +1.48% | +15.31% | 48.42B | |
| +0.85% | -0.70% | +460.88% | +563.55% | 43.66B | |
| -2.40% | -0.23% | +8.13% | +71.41% | 39.51B | |
| -2.01% | -0.85% | +23.85% | +8.73% | 38.95B | |
| +0.38% | -3.23% | - | - | 16.32B | |
| -0.59% | -2.06% | +26.35% | +118.09% | 16.15B | |
| +0.49% | +0.92% | +4.11% | +23.67% | 14.16B | |
| -0.43% | +4.70% | +78.74% | +33.31% | 13.37B | |
| -2.59% | -0.83% | -7.22% | -37.03% | 12.59B | |
| Average | -0.86% | +0.36% | +68.55% | +94.08% | 27.57B | |
| Weighted average by Cap. | -0.99% | +0.53% | +90.83% | +124.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,449B 3.85B 3.33B 3.13B 2.85B 5.35B 369B 5.44B 36.66B 14.33B 185B 14.47B 14.16B 613B | 6,325B 4.47B 3.86B 3.63B 3.3B 6.21B 428B 6.31B 42.55B 16.64B 214B 16.8B 16.43B 712B |
| Net income | 1,485B 1.05B 908M 853M 776M 1.46B 100B 1.48B 9.99B 3.91B 50.31B 3.94B 3.86B 167B | 1,768B 1.25B 1.08B 1.02B 923M 1.74B 120B 1.76B 11.9B 4.65B 59.9B 4.7B 4.59B 199B |
| Net Debt | 1,978B 1.4B 1.21B 1.14B 1.03B 1.94B 134B 1.97B 13.3B 5.2B 66.99B 5.25B 5.14B 223B | 1,262B 893M 771M 725M 659M 1.24B 85.4B 1.26B 8.49B 3.32B 42.77B 3.35B 3.28B 142B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/08/26 | ₩201,000.00 | -0.50% | 341,446 |
| 13/08/26 | ₩202,000.00 | 0.00% | 679,170 |
| 12/08/26 | ₩202,000.00 | -4.04% | 926,438 |
| 11/08/26 | ₩210,500.00 | +4.73% | 886,325 |
| 10/08/26 | ₩201,000.00 | +0.85% | 533,999 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
